Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Inhite Ventures is a prominent venture capital firm founded by Carl Jones, who brings over 25 years of experience in the technology sector. Established in the United States, Inhite Ventures is dedicated to supporting entrepreneurs in building scalable technology companies that drive sustainable growth. The firm has a strong reputation for its focus on innovation and disruptive technology, particularly in the fields of Healthcare (HealthTech) and Artificial Intelligence (AI). With a commitment to fostering the next generation of technology leaders, Inhite Ventures aims to partner with founders who possess strong technical barriers and competitive advantages. The firm is well-positioned to leverage its extensive industry knowledge and network to help portfolio companies navigate the complexities of scaling their businesses. Inhite Ventures typically engages in funding rounds ranging from $1 million to $10 million, making it a key player in the early to growth-stage investment landscape.
Inhite Ventures specializes in investing in innovative technology companies, with a particular emphasis on the Healthcare (HealthTech) and Artificial Intelligence (AI) sectors. The firm targets early-stage to growth-stage companies, providing essential capital to help them scale and achieve their business objectives. Inhite Ventures typically participates in funding rounds ranging from $1 million to $10 million, allowing them to support a diverse range of startups at various stages of development. Additionally, the firm may consider late seed equity rounds for companies that have demonstrated proven concepts and traction in the market. This strategic focus enables Inhite Ventures to identify and back companies that are not only innovative but also have the potential to disrupt their respective industries. By concentrating on sectors that are rapidly evolving and in high demand, Inhite Ventures positions itself as a valuable partner for entrepreneurs looking to make a significant impact in the technology landscape.
Carl Jones - Founder of Inhite Ventures, Carl has over 25 years of experience in the technology sector, focusing on innovation and disruptive technology.
Inhite Ventures invests in various stages, including Pre Seed, Seed, Seed Plus, Series A, Series B, and Growth Equity. This broad range allows them to support companies at different points in their development journey.
To pitch Inhite Ventures, entrepreneurs should prepare a comprehensive presentation that outlines their business model, market opportunity, and competitive advantages. While specific submission guidelines are not provided, a well-structured pitch is essential for capturing the firm's interest.
Inhite Ventures primarily focuses on the Healthcare (HealthTech) and Artificial Intelligence (AI) sectors. They seek innovative technology companies that are poised to disrupt these industries.
The typical check size for Inhite Ventures ranges from $1 million to $10 million. This allows them to provide substantial support to startups as they scale.
Inhite Ventures is based in the United States and primarily invests in companies located within the country. Their focus on the US market allows them to leverage local industry knowledge and networks.
While specific details about the application process are not provided, it is advisable for founders to reach out directly to Inhite Ventures with their pitch materials. A clear and compelling presentation will be crucial for consideration.
Inhite Ventures aims to partner closely with founders, offering insights and resources to help them navigate the challenges of scaling their businesses. Their extensive experience in the technology sector positions them to provide valuable guidance.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.